KIORA PHARMACEUTICALS INC

KPRX

KIORA PHARMACEUTICALS INC

KPRX

Insider Sentiment (TTM):

Last Purchase:2024-09-11Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:339,181Shares Outstanding:4,174,802Institutional Ownership Pct.:8.12%

Earnings Market Reaction:

Filing Date:2026-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	7	11	9	6	1	4	4	6	7	31	2	5
Short Term Investments	10	3	8	14	20	20	23	23	21	-	0	-
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	2	0	0	0	0	0
Accounts Receivable Net Current	1	2	2	1	2	1	1	2	1	0	0	-
Income Taxes Receivable	-	-	-	-	1	1	0	0	2	2	2	1
Assets Current	21	19	22	23	25	27	30	32	32	33	5	7
Assets Noncurrent
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Restricted Cash And Cash Equivalents Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	2	2	2	7	7	7	7	7	9	9	9	9
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	24	21	24	30	32	34	36	39	41	42	14	16
Liabilities And Stockhold…
Liabilities Current
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	-	-	-	-	0	0
Accounts Payable Current	0	1	1	0	0	1	0	1	0	0	0	0
Accrued Liabilities Current	2	2	2	2	3	4	5	2	1	1	1	1
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	2	3	4	3	3	5	6	4	2	2	2	2
Liabilities Noncurrent
Business Combination Contingent Consideration Liab…	3	3	3	3	5	4	4	4	5	5	5	5
Deferred Income Tax Liabilities Net	0	0	0	0	0	0	0	1	1	1	1	1
Contract With Customer Liability Noncurrent	1	1	1	1	1	-	0	-	-	-	-	-
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	-
Liabilities Noncurrent	5	4	4	5	7	5	5	5	6	6	6	6
Liabilities	7	7	8	7	10	10	11	8	8	8	8	8
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	176	171	170	170	170	169	169	169	169	168	153	153
Retained Earnings Accumulated Deficit	-159	-157	-154	-148	-148	-146	-143	-139	-136	-134	-147	-145
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Stockholders Equity	17	14	16	22	22	24	26	30	33	22	6	8
Liabilities And Stockholders Equity	24	21	24	30	32	34	36	39	41	42	14	16
Series A Preferred Stock	-	0	0	0	0	0	0	0	0	0	0	-
Series B Preferred Stock	-	0	0	0	0	0	0	0	0	0	0	-
Series C Preferred Stock	-	0	0	0	0	0	0	0	0	0	0	-
Series D Preferred Stock	-	0	0	0	0	0	0	0	0	0	0	-
Series E Preferred Stock	-	0	0	0	0	0	0	0	0	0	0	-
Series F Preferred Stock	-	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	50	50	50
Common Stock Shares Issued	4	4	4	3	3	3	3	3	3	3	1	1
Shares Outstanding	4	4	4	3	3	3	3	3	3	3	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	9.39%	3.67%	4.08%	-	-	-	-	-	-	-	-	-
2025	-8.31%	-10.77%	-8.00%	17.80%	10.59%	8.47%	-15.02%	-15.45%	-9.01%	23.53%	22.55%	25.00%
2024	1.44%	-3.98%	7.45%	10.45%	2.39%	8.66%	-7.52%	-6.67%	8.65%	-8.22%	6.25%	-0.66%
2023	-	-	-	-13.01%	1.25%	7.31%	-15.90%	-19.44%	-11.11%	-15.66%	-1.89%	2.51%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.97	6.68	5.99	8.79	7.76	5.14	4.94	8.97	19.22	21.02	2.90	3.32
Quick Ratio	8.49	6.25	5.67	8.54	7.46	4.96	4.60	8.84	19.02	20.89	2.76	3.21
Working Capital	18.89M	15.88M	18.12M	20.11M	21.55M	21.83M	23.70M	28.12M	30.17M	31.89M	3.10M	4.88M
Leverage & Debt
Debt to Equity	0.41	0.52	0.50	0.33	0.44	0.44	0.42	0.28	0.23	0.35	1.24	0.96
Interest Coverage TTM	-26.32	-22.97	-18.23	-11.49	-14.51	-12.73	5.54	6.09	4.29	8.02	-97.98	-102.00
Debt Ratio	0.29	0.34	0.34	0.25	0.31	0.30	0.29	0.22	0.19	0.18	0.55	0.49
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.64	0.59	0.53	0.54	0.00	0.00
Days Sales Outstanding TTM	-	-	-	-	-	13,938.52	13.70	40.63	30.56	4.33	-	-
Receivables Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.03	26.65	8.98	11.94	84.25	-	-
Per Share Metrics
Diluted EPS TTM	-1.78	-2.65	-2.64	-1.96	-3.00	-2.86	0.87	1.32	0.77	0.72	-23.26	-16.14
Free Cash Flow Per Share TTM	-1.39	-2.52	-2.42	-2.36	-1.98	-1.87	2.19	1.94	1.14	2.48	-17.76	-11.53
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-55,210.80%	28.15%	30.94%	16.48%	15.95%	-	-
Net Profit Margin TTM	-	-	-	-	-	-60,257.27%	22.44%	34.64%	19.98%	17.55%	-	-
Growth Metrics
Net Revenue Growth (1Y)	-	-100.00%	-100.00%	-100.00%	-100.00%	-99.88%	-	-	-	1,293,351.90%	-100.00%	-100.00%
Net Income Growth (1Y)	-8.31%	-8.23%	-401.42%	-253.92%	-474.44%	-529.21%	-128.73%	-143.55%	-126.45%	-123.62%	-7.88%	-26.20%
EPS Growth (1Y)	-40.79%	-7.30%	-380.15%	-251.24%	-491.49%	-393.31%	-103.99%	-108.16%	-102.32%	-101.70%	-86.07%	-91.19%
Valuation Metrics
P/E TTM	-1.48	-0.73	-0.76	-1.40	-0.96	-1.05	3.56	2.78	5.47	6.52	-0.20	-0.32
P/B TTM	0.96	0.58	0.51	0.53	0.52	0.54	0.50	0.51	0.53	0.85	0.41	0.50
P/S TTM	-	-	-	-	-	634.66	0.80	0.96	1.09	1.14	-	-
Market Cap	16.25M	8.06M	8.21M	11.93M	11.49M	12.69M	12.78M	15.43M	17.52M	18.31M	2.53M	4.04M
Enterprise Value	9.17M	-2.90M	9.83M	6.41M	10.46M	8.92M	8.98M	9.79M	10.94M	-12.97M	68.61K	-1.37M
Calculated Values
Free Cash Flow TTM	-8.61M	-10.53M	-10.07M	-10.11M	-7.92M	-7.87M	8.46M	8.18M	4.74M	7.14M	-9.56M	-9.10M
Net Debt	-7.08M	-10.96M	1.62M	-5.51M	-1.03M	-3.78M	-3.80M	-5.64M	-6.58M	-31.28M	-2.46M	-5.40M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-09-11Purchase

Owner: Stengone, Carmine N.

Title: -

Shares: 1,250

Price/Share: $3.68

Value: $4,600.00

Shares Owned: 1,250

Relationship: Director

Ownership: Direct

2024-09-10Purchase

Owner: Shapiro, Aron

Title: -

Shares: 3,000

Price/Share: $3.60

Value: $10,800.00

Shares Owned: 3,000

Relationship: Director

Ownership: Indirect

2024-08-19Purchase

Owner: Walters-Hoffert, Lisa

Title: -

Shares: 1,250

Price/Share: $3.86

Value: $4,825.00

Shares Owned: 1,250

Relationship: Director

Ownership: Direct

2024-08-19Purchase

Owner: Tyle, Praveen

Title: -

Shares: 5,000

Price/Share: $3.96

Value: $19,800.00

Shares Owned: 5,014

Relationship: Director

Ownership: Direct

2024-08-14Purchase

Owner: Tosca, Melissa

Title: CFO

Shares: 2,000

Price/Share: $3.21

Value: $6,420.00

Shares Owned: 13,599

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-09-11	Stengone, Carmine N.	Director	-	Direct	Purchase	1,250	3.68	$4,600.00	1,250	4
2024-09-10	Shapiro, Aron	Director	-	Indirect	Purchase	3,000	3.60	$10,800.00	3,000	4
2024-08-19	Walters-Hoffert, Lisa	Director	-	Direct	Purchase	1,250	3.86	$4,825.00	1,250	4
2024-08-19	Tyle, Praveen	Director	-	Direct	Purchase	5,000	3.96	$19,800.00	5,014	4
2024-08-14	Tosca, Melissa	Officer	CFO	Direct	Purchase	2,000	3.21	$6,420.00	13,599	4
2024-06-14	Tosca, Melissa	Officer	EVP Finance	Direct	Purchase	100	5.25	$525.00	3,979	4
2024-06-14	Daniels, Eric Joseph	Officer	Chief Development Officer	Direct	Purchase	1,431	5.29	$7,569.99	11,222	4
2024-06-13	Strem, Brian M.	Director,Officer	President and CEO	Direct	Purchase	3,000	5.00	$15,000.00	14,531	4
2024-06-13	Parsons, Erin	Director	-	Indirect	Purchase	5,260	4.88	$25,668.80	5,260	4
2021-11-18	Strem, Brian M.	Director,Officer	President and CEO	Direct	Purchase	17,853	1.41	$25,172.73	27,370	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

8.12%

Inst. Shares: 339,181

Shares Outstanding: 4,174,802

2025-12-31

16.97%

Inst. Shares: 706,945

Shares Outstanding: 4,166,692

2025-09-30

14.36%

Inst. Shares: 616,169

Shares Outstanding: 4,289,853

2025-06-30

23.36%

Inst. Shares: 931,843

Shares Outstanding: 3,989,042

2025-03-31

30.48%

Inst. Shares: 1,285,403

Shares Outstanding: 4,217,007

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	339,181	4,174,802	8.12%
2025-12-31	706,945	4,166,692	16.97%
2025-09-30	616,169	4,289,853	14.36%
2025-06-30	931,843	3,989,042	23.36%
2025-03-31	1,285,403	4,217,007	30.48%
2024-12-31	1,259,460	3,872,644	32.52%
2024-09-30	1,213,569	4,214,950	28.79%
2024-06-30	1,210,489	4,170,627	29.02%
2024-03-31	11,096,123	2,881,796	-
2023-12-31	255,632	538,007	47.51%
2023-09-30	160,053	789,656	20.27%
2023-06-30	629,388	365,530	172.19%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

KIORA PHARMACEUTICALS INC (KPRX) — SEC Financial Statements & Analysis

KIORA PHARMACEUTICALS INC (KPRX) is a pharmaceutical preparations company, incorporated in DE. KIORA PHARMACEUTICALS INC trades on Nasdaq, OTC as: KPRX, KPHMW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), KIORA PHARMACEUTICALS INC reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.41x, a Price-to-Sales (P/S) ratio of 634.66x (TTM), a Price-to-Book (P/B) ratio of 0.96x (TTM), at a market cap of $16.25M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.41x
P/S TTM: 634.66x
P/B TTM: 0.96x
Market Cap: $16.25M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is KIORA PHARMACEUTICALS INC in?

KIORA PHARMACEUTICALS INC (KPRX) operates in the Pharmaceutical Preparations industry.

What is KPRX's market cap?

KIORA PHARMACEUTICALS INC (KPRX) has a market capitalization of $16.25M as of 2026-06-30.

What exchange does KPRX trade on?

KIORA PHARMACEUTICALS INC (KPRX) trades on the Nasdaq, OTC.

Where is KIORA PHARMACEUTICALS INC incorporated?

KIORA PHARMACEUTICALS INC is incorporated in DE.